Versigent (NYSE: VGNT) reported third-quarter 2026 net sales of $2,450 million, up 7.2% from the same quarter last year. Adjusted sales growth, excluding commodity and currency movements, was approximately 1%. Net income attributable to Versigent fell to $102 million from $109 million; diluted earnings per share declined to $1.41 from $1.54. Adjusted EBITDA rose 10.9% to $275 million, with its margin up 40 basis points to 11.2%.
Operating cash flow was $225 million, while free cash flow fell to $170 million from $179 million as capital spending increased. Versigent raised its 2026 sales guidance midpoint on higher commodity pass-throughs and now expects $9,500–$9,600 million. It narrowed adjusted EBITDA guidance to $970–$1,010 million and raised free cash flow guidance to $275–$325 million. The board declared a $0.13 quarterly dividend, payable December 17, 2026, to holders of record December 4.
Versigent (NYSE: VGNT) will release its third-quarter 2026 financial results before the market opens on November 4, 2026.
Chief Executive Officer Joe Liotine and Chief Financial Officer Doug Ostermann will host a webcast and conference call at 8 a.m. ET that day. The earnings release, presentation materials and webcast will be available on the company's investor relations website. A webcast replay will be available approximately two hours after the call concludes and for three months thereafter.
Versigent (NYSE: VGNT) reported second-quarter 2026 net sales of $2,444 million, up 10.8% year-over-year, with Adjusted Net Sales Growth of about 5%. Net income attributable to Versigent rose to $118 million and diluted EPS to $1.64, while Adjusted Diluted EPS reached $1.92. Adjusted EBITDA increased 24.8% to $272 million, expanding margin to 11.1%, up 120 basis points.
Net cash from operating activities was $158 million, and Free Cash Flow was $107 million, including $22 million of separation-related costs. The Board declared an inaugural quarterly dividend of $0.13 per share, payable September 18, 2026. Versigent raised full-year 2026 net sales guidance to $9.4–$9.6 billion, while reaffirming Adjusted EBITDA guidance of $950–$1,030 million and Free Cash Flow guidance of $200–$300 million.
Versigent (NYSE: VGNT) will release its Q2 2026 financial results before the New York Stock Exchange opens on Tuesday, August 4, 2026. Management will discuss the results on a conference call at 9:00 a.m. Eastern Time, hosted by CEO Joe Liotine and CFO Doug Ostermann.
A live webcast and presentation materials will be available on Versigent’s Investor Relations website (ir.versigent.com), with a replay accessible about two hours after the call. Investors can also join by telephone using U.S. dial-in +1-800-330-6710 or international dial-in +1-213-279-1505, referencing conference ID 1768848.
Versigent (NYSE: VGNT) announced management participation in two June 2026 investor conferences in New York City.
Events include the UBS Auto and Auto Tech Conference on June 3, 2026, featuring a webcast fireside chat, and the Wolfe Research Autos and Mobility Conference on June 18, 2026.
Versigent (NYSE: VGNT) reported First Quarter 2026 results: revenue $2,212M (+9%), net income attributable to Versigent $78M, adjusted EBITDA $203M (9.2% margin), and free cash flow $(30)M. The company reaffirmed full‑year 2026 guidance: revenue $9,100–$9,400M, U.S. GAAP net income $315–$375M, adjusted EBITDA $950–$1,030M, and free cash flow $200–$300M.
In April 2026 the board approved a $0.13 per share quarterly dividend policy (to be declared) and a $250M share repurchase program.
Versigent (NYSE: VGNT) will release first quarter 2026 results on May 5, 2026 after market close and host a conference call at 4:15 p.m. ET the same day.
The call will be led by CEO Joe Liotine and CFO Doug Ostermann, with a live webcast, presentation materials and a replay available on the Versigent Investor Relations website. Q1 results are presented on a carve-out basis from Aptiv historical accounting, consistent with Versigent's Form 10 registration.
Versigent (NYSE: VGNT) launched as an independent public company on April 1, 2026, following a tax-free spin-off from Aptiv. Shares begin trading under VGNT and leadership rang the NYSE Opening Bell.
Versigent starts with $8.8B revenue, $528M net income, and $893M adjusted EBITDA for 2025, expects >3% top-line growth, plans >200 bps EBITDA margin expansion over three years, and targets $1B free cash flow by 2028. Distribution: one Versigent share per three Aptiv shares; fractional-share cash paid. First-quarter results due May 5, 2026.
Aptiv (NYSE: APTV) will release Q1 2026 financial results on May 5, 2026 prior to market open and hold an investor call at 8:00 a.m. ET. Results will report Total Aptiv with Electrical Distribution Systems (EDS) as a segment.
Versigent (NYSE: VGNT), the EDS carve-out expected to spin off on April 1, 2026, will release Q1 2026 results on May 5, 2026 following market close and host a call at 4:15 p.m. ET. Webcasts, presentation materials, replays, and dial-in details are available on each company’s investor relations site.
Versigent (NYSE:VGNT) will be added to the S&P SmallCap 600 prior to the open on April 2, 2026, replacing Titan International (NYSE:TWI). The spin-off of Versigent from Aptiv (NYSE:APTV) is expected to complete on April 1, 2026, with Aptiv remaining in the S&P 500.
S&P Dow Jones Indices cited Titan's market capitalization as no longer representative of the small-cap market, prompting the deletion and index reconstitution.